Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 2/2024

31.08.2023 | Cornea

Factors affecting long-term changes of meibomian gland in MGD patients

verfasst von: Xichen Wan, Yuqing Wu, Zimeng Zhai, Pei Yang, Shuyun Zhou, Han Ye, Yiteng Lu, Feng Zhou, Xujiao Zhou, Jiaxu Hong

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 2/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To explore the long-term course of patients with meibomian gland dysfunction (MGD), and to analyse potential factors affecting the recovery of meibomian gland (MG) dropout.

Methods

Seventy-nine MGD patients (79 eyes) aged 36.03±15.78 years old who underwent more than one year of follow-up were enrolled in this retrospective study. Corneal fluorescein staining (CFS), tear meniscus height (TMH), noninvasive breakup time (NIBUT), and noncontact meibography at baseline and last visit were collected and analysed. Then an automatic MG analyzer was used to measure the morphological and functional parameters of MGs, including their area ratio (AR), tortuosity index (TI), and signal index (SI). The patients whose AR increased by more than 5% were defined as MG improvement, and AR decreased by more than 5% was MG worsening.

Results

A total of 79 patients (79 eyes) were assessed with at least 1-year of follow-up. More than 1/3 of MGD patients (27 eyes, 34.2%) underwent MG improvement, and 30.4% of MGs became worsened. Age (P=0.002), gender (P<0.001), IPL treatment (P=0.013), the change of CFS (P=0.0015), and the recovery of SI (P=0.035) showed significant differences among different recovery groups. Age(P<0.001), female sex (P=0.003), ΔCFS (P<0.001), AR at baseline (P<0.001) were negative correlation with AR recovery, and the change of SI (P=0.003) and IPL treatment (P=0.003) had a positive correlation with it. Among them, age (P=0.038), the change of CFS (P=0.004), and AR at baseline (P=0.007) were confirmed as negatively correlated factors predicting the long-term change of the MG.

Conclusion

Although the MGD treatment has continued for more than 1 year, only 34.2% of MGD patients were observed to undergo MG improvement. Younger patients and patients with better CFS recovery seem to have more opportunities to improve their MGs.
Literatur
1.
Zurück zum Zitat Geerling G, Baudouin C, Aragona P et al (2017) Emerging strategies for the diagnosis and treatment of meibomian gland dysfunction: proceedings of the OCEAN group meeting. Ocul Surf 15:179–192CrossRefPubMed Geerling G, Baudouin C, Aragona P et al (2017) Emerging strategies for the diagnosis and treatment of meibomian gland dysfunction: proceedings of the OCEAN group meeting. Ocul Surf 15:179–192CrossRefPubMed
2.
Zurück zum Zitat Stapleton F, Alves M, Bunya VY et al (2017) TFOS DEWS II epidemiology report. Ocul Surf 15:334–365CrossRefPubMed Stapleton F, Alves M, Bunya VY et al (2017) TFOS DEWS II epidemiology report. Ocul Surf 15:334–365CrossRefPubMed
3.
Zurück zum Zitat Siak JJ, Tong L, Wong WL et al (2012) Prevalence and risk factors of meibomian gland dysfunction: the Singapore Malay eye study. Cornea 31:1223–1228CrossRefPubMed Siak JJ, Tong L, Wong WL et al (2012) Prevalence and risk factors of meibomian gland dysfunction: the Singapore Malay eye study. Cornea 31:1223–1228CrossRefPubMed
4.
Zurück zum Zitat Deng Y, Wang Q, Luo Z et al (2021) Quantitative analysis of morphological and functional features in meibography for meibomian gland dysfunction: diagnosis and grading. EClinicalMedicine 40:101132CrossRefPubMedPubMedCentral Deng Y, Wang Q, Luo Z et al (2021) Quantitative analysis of morphological and functional features in meibography for meibomian gland dysfunction: diagnosis and grading. EClinicalMedicine 40:101132CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Sheppard JD, Nichols KK (2023) Dry eye disease associated with meibomian gland dysfunction: focus on tear film characteristics and the therapeutic landscape. Ophthalmol Ther 12:1397–1418CrossRefPubMedPubMedCentral Sheppard JD, Nichols KK (2023) Dry eye disease associated with meibomian gland dysfunction: focus on tear film characteristics and the therapeutic landscape. Ophthalmol Ther 12:1397–1418CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Ha M, Oh SE, Whang WJ et al (2022) Relationship between meibomian gland loss in infrared meibography and meibum quality in dry eye patients. BMC Ophthalmol 22:292CrossRefPubMedPubMedCentral Ha M, Oh SE, Whang WJ et al (2022) Relationship between meibomian gland loss in infrared meibography and meibum quality in dry eye patients. BMC Ophthalmol 22:292CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Saha RK, Chowdhury AM, Na KS et al (2022) Automated quantification of meibomian gland dropout in infrared meibography using deep learning. Ocul Surf 26:283–294CrossRefPubMed Saha RK, Chowdhury AM, Na KS et al (2022) Automated quantification of meibomian gland dropout in infrared meibography using deep learning. Ocul Surf 26:283–294CrossRefPubMed
8.
Zurück zum Zitat Wu Y, Li H, Tang Y et al (2017) Morphological evaluation of meibomian glands in children and adolescents using noncontact infrared meibography. J Pediatr Ophthalmol Strabismus 54:78–83CrossRefPubMed Wu Y, Li H, Tang Y et al (2017) Morphological evaluation of meibomian glands in children and adolescents using noncontact infrared meibography. J Pediatr Ophthalmol Strabismus 54:78–83CrossRefPubMed
10.
Zurück zum Zitat Yin Y, Gong L (2017) Reversibility of Gland Dropout and Significance of Eyelid Hygiene Treatment in Meibomian Gland Dysfunction. Cornea 36:332–337CrossRefPubMed Yin Y, Gong L (2017) Reversibility of Gland Dropout and Significance of Eyelid Hygiene Treatment in Meibomian Gland Dysfunction. Cornea 36:332–337CrossRefPubMed
11.
Zurück zum Zitat Wu Y, Jiang H, Zhou X et al (2022) Morphological and functional changes of meibomian glands in pediatric and adult patients with allergic conjunctivitis. J Clin Med 11:1427CrossRefPubMedPubMedCentral Wu Y, Jiang H, Zhou X et al (2022) Morphological and functional changes of meibomian glands in pediatric and adult patients with allergic conjunctivitis. J Clin Med 11:1427CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Zhai Z, Jiang H, Wu Y et al (2022) Safety and feasibility of low fluence intense pulsed light for treating pediatric patients with moderate-to-severe blepharitis. J Clin Med 11:3080CrossRefPubMedPubMedCentral Zhai Z, Jiang H, Wu Y et al (2022) Safety and feasibility of low fluence intense pulsed light for treating pediatric patients with moderate-to-severe blepharitis. J Clin Med 11:3080CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Arita R, Suehiro J, Haraguchi T et al (2013) Topical diquafosol for patients with obstructive meibomian gland dysfunction. Br J Ophthalmol 97:725–729CrossRefPubMed Arita R, Suehiro J, Haraguchi T et al (2013) Topical diquafosol for patients with obstructive meibomian gland dysfunction. Br J Ophthalmol 97:725–729CrossRefPubMed
15.
Zurück zum Zitat Arita R, Fukuoka S, Morishige N (2019) Therapeutic efficacy of intense pulsed light in patients with refractory meibomian gland dysfunction. Ocul Surf 17:104–110CrossRefPubMed Arita R, Fukuoka S, Morishige N (2019) Therapeutic efficacy of intense pulsed light in patients with refractory meibomian gland dysfunction. Ocul Surf 17:104–110CrossRefPubMed
17.
Zurück zum Zitat Hwang HS, Parfitt GJ, Brown DJ et al (2017) Meibocyte differentiation and renewal: Insights into novel mechanisms of meibomian gland dysfunction (MGD). Exp Eye Res 163:37–45CrossRefPubMedPubMedCentral Hwang HS, Parfitt GJ, Brown DJ et al (2017) Meibocyte differentiation and renewal: Insights into novel mechanisms of meibomian gland dysfunction (MGD). Exp Eye Res 163:37–45CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Reneker LW, Irlmeier RT, Shui YB et al (2020) Histopathology and selective biomarker expression in human meibomian glands. Br J Ophthalmol 104:999–1004CrossRefPubMed Reneker LW, Irlmeier RT, Shui YB et al (2020) Histopathology and selective biomarker expression in human meibomian glands. Br J Ophthalmol 104:999–1004CrossRefPubMed
20.
Zurück zum Zitat Chen Y, Li J, Wu Y et al (2021) Comparative evaluation in intense pulsed light therapy combined with or without meibomian gland expression for the treatment of meibomian gland dysfunction. Curr Eye Res 46:1125–1131CrossRefPubMed Chen Y, Li J, Wu Y et al (2021) Comparative evaluation in intense pulsed light therapy combined with or without meibomian gland expression for the treatment of meibomian gland dysfunction. Curr Eye Res 46:1125–1131CrossRefPubMed
21.
Zurück zum Zitat Ferrari G, Colucci A, Barbariga M et al (2019) High frequency electrotherapy for the treatment of meibomian gland dysfunction. Cornea 38:1424–1429CrossRefPubMed Ferrari G, Colucci A, Barbariga M et al (2019) High frequency electrotherapy for the treatment of meibomian gland dysfunction. Cornea 38:1424–1429CrossRefPubMed
22.
Zurück zum Zitat Cuevas M, González-García M, Castellanos E et al (2012) Correlations among symptoms, signs, and clinical tests in evaporative-type dry eye disease caused by Meibomian gland dysfunction (MGD). Curr Eye Res 37:855–863CrossRefPubMed Cuevas M, González-García M, Castellanos E et al (2012) Correlations among symptoms, signs, and clinical tests in evaporative-type dry eye disease caused by Meibomian gland dysfunction (MGD). Curr Eye Res 37:855–863CrossRefPubMed
23.
Zurück zum Zitat Daniel E, Maguire MG, Pistilli M et al (2019) Grading and baseline characteristics of meibomian glands in meibography images and their clinical associations in the Dry Eye Assessment and Management (DREAM) study. Ocul Surf 17:491–501CrossRefPubMedPubMedCentral Daniel E, Maguire MG, Pistilli M et al (2019) Grading and baseline characteristics of meibomian glands in meibography images and their clinical associations in the Dry Eye Assessment and Management (DREAM) study. Ocul Surf 17:491–501CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Kim HM, Eom Y, Song JS (2018) The relationship between morphology and function of the meibomian glands. Eye Contact Lens 44:1–5CrossRefPubMed Kim HM, Eom Y, Song JS (2018) The relationship between morphology and function of the meibomian glands. Eye Contact Lens 44:1–5CrossRefPubMed
25.
Zurück zum Zitat Ballesteros-Sánchez A, Gargallo-Martínez B, Sánchez-González MC et al (2013) Intense pulse light combined with low-level light therapy in dry eye disease: a systematic review. Eye Contact Lens 49:8–13CrossRef Ballesteros-Sánchez A, Gargallo-Martínez B, Sánchez-González MC et al (2013) Intense pulse light combined with low-level light therapy in dry eye disease: a systematic review. Eye Contact Lens 49:8–13CrossRef
26.
Zurück zum Zitat Yin Y, Liu N, Gong L et al (2018) Changes in the meibomian gland after exposure to intense pulsed light in meibomian gland dysfunction (MGD) patients. Curr Eye Res 43:308–313CrossRefPubMed Yin Y, Liu N, Gong L et al (2018) Changes in the meibomian gland after exposure to intense pulsed light in meibomian gland dysfunction (MGD) patients. Curr Eye Res 43:308–313CrossRefPubMed
Metadaten
Titel
Factors affecting long-term changes of meibomian gland in MGD patients
verfasst von
Xichen Wan
Yuqing Wu
Zimeng Zhai
Pei Yang
Shuyun Zhou
Han Ye
Yiteng Lu
Feng Zhou
Xujiao Zhou
Jiaxu Hong
Publikationsdatum
31.08.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 2/2024
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-023-06210-1

Weitere Artikel der Ausgabe 2/2024

Graefe's Archive for Clinical and Experimental Ophthalmology 2/2024 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Die überschießende Wundheilung in der filtrierenden Glaukomchirurgie ist ein zentraler Faktor für ein operatives Versagen. Nach der Einführung der Trabekulektomie in den 1960er-Jahren wurden viele Faktoren erkannt, die mit einer vermehrten …

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.